Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EVL |
| Upstream (Parents) |
|---|
| (<<) FZD4 → EVL |
| (<<) VCAM1 → EVL |
| (<<) IL10RA → EVL |
| Downstream (Children) |
|---|
| EVL → POU5F1P4///POU5F1P3///POU5F1B///POU5F1 (>>) |
| EVL → TENC1 (>>) |
| EVL → USH2A (>>) |
| EVL → LCK (>>) |
| EVL → LOC220077 (>>) |
| EVL → DNAI2 (>>) |
| EVL → KLK3 (>>) |
| EVL → IFNB1 (>>) |
| EVL → WDR1 (>>) |
| EVL → IL10RA (>>) |
| EVL → PLK2 (>>) |
| EVL → HLX (>>) |
| EVL → WHSC1L1 (>>) |
| EVL → CSH1 (>>) |
| EVL → TK2 (>>) |
| EVL → ARHGEF6 (>>) |
| EVL → SDC3 (>>) |
| EVL → CAMK1 (>>) |
| EVL → SEPT6 (>>) |
| EVL → TNF (>>) |
